HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William T Creasman Selected Research

Hemorrhage

10/2017Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William T Creasman Research Topics

Disease

15Neoplasms (Cancer)
11/2018 - 01/2002
7Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2017 - 12/2003
6Endometrial Neoplasms (Endometrial Cancer)
11/2018 - 12/2003
6Breast Neoplasms (Breast Cancer)
05/2013 - 05/2005
5Ovarian Neoplasms (Ovarian Cancer)
12/2016 - 01/2002
3Carcinoma (Carcinomatosis)
01/2017 - 06/2008
2Carcinosarcoma
12/2017 - 05/2013
2Endometrioid Carcinoma
12/2017 - 05/2013
2Uterine Neoplasms (Uterine Cancer)
01/2016 - 06/2008
2Neoplasm Metastasis (Metastasis)
09/2015 - 09/2005
2Atrophy
01/2006 - 01/2006
2Cardiovascular Diseases (Cardiovascular Disease)
01/2006 - 01/2006
2Atypical Squamous Cells of the Cervix
09/2005 - 12/2003
1Adenocarcinoma
12/2017
1Fistula
10/2017
1Hemorrhage
10/2017
1Thromboembolism
10/2017
1Wounds and Injuries (Trauma)
10/2017
1Disease Progression
10/2017
1Residual Neoplasm
12/2016
1Lymphatic Metastasis
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2012
1Uterine Cervical Dysplasia
09/2005
1Lymphadenopathy
02/2004

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
11/2009 - 05/2005
5Estrogens (Estrogen)FDA Link
01/2006 - 07/2002
3Progestins (Progestagens)IBA
01/2006 - 05/2005
2Cisplatin (Platino)FDA LinkGeneric
10/2017 - 08/2007
2Insulin-Like Growth Factor II (Somatomedin A)IBA
09/2005 - 12/2003
2Insulin-Like Growth Factor Binding Protein 3IBA
09/2005 - 12/2003
1MicroRNAs (MicroRNA)IBA
12/2017
1Paclitaxel (Taxol)FDA LinkGeneric
10/2017
1Bevacizumab (Avastin)FDA Link
10/2017
1CreatinineIBA
10/2017
1Proteins (Proteins, Gene)FDA Link
10/2017
1Topotecan (Hycamtin)FDA LinkGeneric
10/2017
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2017
1SynucleinsIBA
01/2017
1Indicators and Reagents (Reagents)IBA
01/2016
1ORALIT (ORS)IBA
09/2015
1TamoxifenFDA LinkGeneric
05/2013
1Histones (Histone)IBA
01/2013
1GTP-Binding Proteins (G-Protein)IBA
01/2013
1Vincristine (Oncovin)FDA LinkGeneric
08/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2005
1ProgesteroneFDA LinkGeneric
09/2005
1Biomarkers (Surrogate Marker)IBA
09/2005
1Vascular Endothelial Growth FactorsIBA
09/2005
1Vascular Endothelial Growth Factor CIBA
09/2005
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2003
1DNA (Deoxyribonucleic Acid)IBA
01/2002
1RNA (Ribonucleic Acid)IBA
01/2002
1AcridinesIBA
01/2002
19-methoxyacridineIBA
01/2002
1NSC 366140 (pyrazoloacridine)IBA
01/2002
1PlatinumIBA
01/2002

Therapy/Procedure

10Therapeutics
12/2017 - 12/2003
7Hysterectomy
11/2018 - 02/2004
5Radiotherapy
11/2018 - 02/2005
4Drug Therapy (Chemotherapy)
11/2018 - 01/2002
3Lymph Node Excision (Lymph Node Dissection)
04/2012 - 08/2007
1Cytoreduction Surgical Procedures
12/2016
1Tubal Sterilization (Tubal Ligation)
09/2015
1Conservative Treatment
04/2012
1Salpingo-oophorectomy
06/2008
1Laparotomy
08/2007
1Secondary Prevention
09/2005
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2005